Comprehensive analysis of EphA2 in pan-cancer: A prognostic biomarker associated with cancer immunity.
Yuchun LiHanxiao FeiZhiwen XiaoXiuxia LuHua ZhangMengmeng Liu
Published in: Clinical and experimental pharmacology & physiology (2024)
Our first pan-cancer study of EphA2 provides insight into the prognostic and immunological roles of EphA2 in different tumours, suggesting that EphA2 might be a potential biomarker for poor prognosis and immune infiltration in cancer.